|Precision Therapeutics is a CLIA-certified clinical laboratory
website designed by ocreations.com
Product of Precision Therapeutics
Each and every patient's cancer is unique. That's why we at Precision Therapeutics believe in ensuring that every patient receives treatment that is customized to his or her individual needs.
Our mission is simple: support physicians in their treatment decisions and improve the chances for a better quality of life for those living with cancer.
The ChemoFx® drug response marker helps improve patient outcomes by supporting physicians in the selection of effective treatments for their gynecologic cancer patients. It's a test that quantifies an individual gynecologic cancer patient's probable tumor response to various chemotherapeutic and biologic agents. While not intended to replace standard of care therapy, ChemoFx® provides valuable insights that support physicians' treatment decisions and give both physicians and patients an edge against gynecologic cancer.